Entries by iNFixion Bioscience

iNFixion Bioscience announces second NIH SBIR Phase 1 Grant award

iNFixion Bioscience announced today that it had been granted its second NIH Phase 1 SBIR Grant award from the National Institute of Neurological Disorders and Stroke (NINDS).  This 18-month grant, titled “Inhibition of NF1 Protein Degradation as a Treatment for NF1 Haploinsufficiency” is focused on identifying small molecule compounds that impact the rate of intracellular […]

/by

iNFixion Bioscience launches building of tools to help study NF1 haploinsufficiency

iNFixion Bioscience announced ongoing collaborations with individual researchers from the University of Arizona, the University of Alabama Huntsville, and the Broad Institute in order to build tools to study NF1 haploinsufficiency.  These projects include developing machine learning models to identify compounds impacting NF1 gene expression and the development of synthetic transcription factors to specifically increase […]

/by

SIGN UP FOR THE iNFixion Bioscience

Newsletter

Receive occasional updates sharing iNFixion’s progress and other newsworthy events.

CONSENT
This field is for validation purposes and should be left unchanged.

Ⓒ iNFixion Bioscience (2017-2023). All rights reserved.

Investors & News    |   Contact us   |   LinkedIn